Evidence map›Paper›PMID 20011587›Full record

ArticlePloS one2009

RNA editing genes associated with extreme old age in humans and with lifespan in C. elegans.

Paola Sebastiani, Monty Montano, Annibale Puca, Nadia Solovieff, Toshio Kojima, Meng C Wang, Efthymia Melista, Micah Meltzer, Sylvia E J Fischer, Stacy Andersen and 19 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. APOE Alleles and Extreme Human Longevity.The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Targeting RNA adenosine editing and modification enzymes for RNA therapeutics.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

29 authors at 15 institutions in 3 countries.

Paola SebastianiDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America. sebas@bu.edu
Monty Montano
Annibale Puca
Nadia Solovieff
Toshio Kojima
Meng C Wang
Efthymia Melista
Micah Meltzer
Sylvia E J Fischer
Stacy Andersen
Stephen H Hartley
Amanda Sedgewick
Yasumichi Arai
Aviv Bergman
Nir Barzilai
Dellara F Terry
Alberto Riva
Chiara Viviani Anselmi
Alberto Malovini
Aya Kitamoto
Motoji Sawabe
Tomio Arai
Yasuyuki Gondo
Martin H Steinberg
Nobuyoshi Hirose
Gil Atzmon
Gary Ruvkun
Clinton T Baldwin
Thomas T Perls
Boston University · USMultiMedica · ITAlbert Einstein College of Medicine · USCenter for Human Genetics · USKeio University · JPHarvard University · USHarvard University Press · USMassachusetts General Hospital · USOsaka University · JPRIKEN · JPRIKEN Advanced Science Institute · JPTokyo Metropolitan Geriatric Hospital · JPTokyo Metropolitan Institute of Gerontology · JPUniversity of Florida · USYeshiva University · US

Funding

Stable Isotope and Metabolomics CoreP60DK020541 · NIDDK · YESHIVA UNIVERSITY · PI FLEISCHER, NORMAN S. · 1986 to 2014
$29.8M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
WEIGHT MGT &NUTRITION FOR PRE-/PERIMENOPAUSAL BREAST CANCER SURVIVORSM01RR012248 · NCRR · YESHIVA UNIVERSITY · PI RIEDER, JESSICA · 1997 to 2008
$18.4M
STATISTICS AND DATA MANAGEMENT COREP01AG027734 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BARZILAI, NIR J · 2007 to 2012
$9.3M
Genome-Wide Association Studies in Sickle Cell Anemia and in CentenariansR01HL087681 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI STEINBERG, MARTIN H. · 2007 to 2010
$6.0M
Longevity Genes in Founder PopulationsR01AG018728 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2001 to 2005
$3.8M
Macrophage-Muscle Precursor Cell Interaction in the Context of HIV InfectionR01AR055115 · NIAMS · BOSTON MEDICAL CENTER · PI MONTANO, MONTY A · 2007 to 2011
$1.8M
GENETIC FACTORS CAUSING LONGEVITY IN CENTENARIANS AND THEIR OFFSPRINGR01AG027216 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BALDWIN, CLINTON T · 2006 to 2008
$974k
Characterizing Human Exceptional LongevityK24AG025727 · NIA · BOSTON MEDICAL CENTER · PI PERLS, THOMAS T · 2006 to 2010
$789k
NCRR NIH HHS M01 RR012248NCRR NIH HHS M01-RR12248NCRR NIH HHS RR-12248NHLBI NIH HHS R01 HL087681NIAMS NIH HHS R01 AR055115NIA NIH HHS AG-027734NIA NIH HHS AG-18728NIA NIH HHS K24 AG025727NIA NIH HHS P01 AG027734NIA NIH HHS R01 AG018728NIA NIH HHS R01 AG027216NIDDK NIH HHS DK-20541NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P60 DK020541
6 · The paper itself

Abstract

backgroundThe strong familiality of living to extreme ages suggests that human longevity is genetically regulated. The majority of genes found thus far to be associated with longevity primarily function in lipoprotein metabolism and insulin/IGF-1 signaling. There are likely many more genetic modifiers of human longevity that remain to be discovered. METHODOLOGY/PRINCIPAL

findingsHere, we first show that 18 single nucleotide polymorphisms (SNPs) in the RNA editing genes ADARB1 and ADARB2 are associated with extreme old age in a U.S. based study of centenarians, the New England Centenarian Study. We describe replications of these findings in three independently conducted centenarian studies with different genetic backgrounds (Italian, Ashkenazi Jewish and Japanese) that collectively support an association of ADARB1 and ADARB2 with longevity. Some SNPs in ADARB2 replicate consistently in the four populations and suggest a strong effect that is independent of the different genetic backgrounds and environments. To evaluate the functional association of these genes with lifespan, we demonstrate that inactivation of their orthologues adr-1 and adr-2 in C. elegans reduces median survival by 50%. We further demonstrate that inactivation of the argonaute gene, rde-1, a critical regulator of RNA interference, completely restores lifespan to normal levels in the context of adr-1 and adr-2 loss of function. CONCLUSIONS/SIGNIFICANCE: Our results suggest that RNA editors may be an important regulator of aging in humans and that, when evaluated in C. elegans, this pathway may interact with the RNA interference machinery to regulate lifespan.

Indexed as

Adenosine DeaminaseAdolescentAdultAgedAged, 80 and overAlgorithmsAnimalsCaenorhabditis elegansChromosomes, Human, Pair 10FemaleGene FrequencyGenes, HelminthGenotypeHumansLinkage DisequilibriumLongevityADARB1 protein, humanAdenosine DeaminaseRNA-Binding Proteins

Identifiers

PMID20011587
PMCPMC2788130
OpenAlexW2042979946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.